nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.724	1	CbGbCtD
Bezafibrate—PPARG—forelimb—amyotrophic lateral sclerosis	0.0078	0.147	CbGeAlD
Bezafibrate—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0072	0.0616	CcSEcCtD
Bezafibrate—PPARG—hindlimb—amyotrophic lateral sclerosis	0.00702	0.132	CbGeAlD
Bezafibrate—PPARG—appendage—amyotrophic lateral sclerosis	0.00602	0.113	CbGeAlD
Bezafibrate—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00495	0.0424	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00413	0.0354	CcSEcCtD
Bezafibrate—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0351	CcSEcCtD
Bezafibrate—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00402	0.0344	CcSEcCtD
Bezafibrate—Eczema—Riluzole—amyotrophic lateral sclerosis	0.004	0.0343	CcSEcCtD
Bezafibrate—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00373	0.032	CcSEcCtD
Bezafibrate—PPARA—embryo—amyotrophic lateral sclerosis	0.00364	0.0684	CbGeAlD
Bezafibrate—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00354	0.0303	CcSEcCtD
Bezafibrate—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0284	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00324	0.0277	CcSEcCtD
Bezafibrate—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00318	0.0273	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00317	0.0272	CcSEcCtD
Bezafibrate—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00317	0.0272	CcSEcCtD
Bezafibrate—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0266	CcSEcCtD
Bezafibrate—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0256	CcSEcCtD
Bezafibrate—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0253	CcSEcCtD
Bezafibrate—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00286	0.0245	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00284	0.0243	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0234	CcSEcCtD
Bezafibrate—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00272	0.0233	CcSEcCtD
Bezafibrate—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0211	CcSEcCtD
Bezafibrate—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00246	0.021	CcSEcCtD
Bezafibrate—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00244	0.0209	CcSEcCtD
Bezafibrate—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0201	CcSEcCtD
Bezafibrate—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0022	0.0188	CcSEcCtD
Bezafibrate—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00213	0.0183	CcSEcCtD
Bezafibrate—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0178	CcSEcCtD
Bezafibrate—PPARD—nervous system—amyotrophic lateral sclerosis	0.00205	0.0386	CbGeAlD
Bezafibrate—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.002	0.0171	CcSEcCtD
Bezafibrate—PPARG—embryo—amyotrophic lateral sclerosis	0.002	0.0376	CbGeAlD
Bezafibrate—PPARD—central nervous system—amyotrophic lateral sclerosis	0.00197	0.0371	CbGeAlD
Bezafibrate—PPARD—cerebellum—amyotrophic lateral sclerosis	0.00193	0.0363	CbGeAlD
Bezafibrate—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00184	0.0158	CcSEcCtD
Bezafibrate—Infection—Riluzole—amyotrophic lateral sclerosis	0.00176	0.015	CcSEcCtD
Bezafibrate—PPARA—nervous system—amyotrophic lateral sclerosis	0.00175	0.0329	CbGeAlD
Bezafibrate—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0148	CcSEcCtD
Bezafibrate—PPARA—central nervous system—amyotrophic lateral sclerosis	0.00168	0.0316	CbGeAlD
Bezafibrate—PPARA—cerebellum—amyotrophic lateral sclerosis	0.00164	0.0309	CbGeAlD
Bezafibrate—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00161	0.0138	CcSEcCtD
Bezafibrate—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0016	0.0137	CcSEcCtD
Bezafibrate—PPARD—brain—amyotrophic lateral sclerosis	0.00157	0.0295	CbGeAlD
Bezafibrate—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0133	CcSEcCtD
Bezafibrate—HMGCR—medulla oblongata—amyotrophic lateral sclerosis	0.00155	0.0291	CbGeAlD
Bezafibrate—Pain—Riluzole—amyotrophic lateral sclerosis	0.00151	0.0129	CcSEcCtD
Bezafibrate—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00151	0.0129	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0124	CcSEcCtD
Bezafibrate—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0014	0.012	CcSEcCtD
Bezafibrate—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0014	0.012	CcSEcCtD
Bezafibrate—HMGCR—spinal cord—amyotrophic lateral sclerosis	0.00138	0.026	CbGeAlD
Bezafibrate—PPARA—brain—amyotrophic lateral sclerosis	0.00133	0.0251	CbGeAlD
Bezafibrate—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0112	CcSEcCtD
Bezafibrate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0107	CcSEcCtD
Bezafibrate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0104	CcSEcCtD
Bezafibrate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00117	0.01	CcSEcCtD
Bezafibrate—HMGCR—nervous system—amyotrophic lateral sclerosis	0.00116	0.0219	CbGeAlD
Bezafibrate—HMGCR—central nervous system—amyotrophic lateral sclerosis	0.00112	0.0211	CbGeAlD
Bezafibrate—Rash—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00954	CcSEcCtD
Bezafibrate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00953	CcSEcCtD
Bezafibrate—Headache—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00948	CcSEcCtD
Bezafibrate—HMGCR—cerebellum—amyotrophic lateral sclerosis	0.00109	0.0206	CbGeAlD
Bezafibrate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00899	CcSEcCtD
Bezafibrate—PPARG—nervous system—amyotrophic lateral sclerosis	0.00096	0.0181	CbGeAlD
Bezafibrate—PPARG—central nervous system—amyotrophic lateral sclerosis	0.000924	0.0174	CbGeAlD
Bezafibrate—HMGCR—brain—amyotrophic lateral sclerosis	0.000888	0.0167	CbGeAlD
Bezafibrate—PPARG—brain—amyotrophic lateral sclerosis	0.000734	0.0138	CbGeAlD
Bezafibrate—PPARG—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.000728	0.00689	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000713	0.00675	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000706	0.00668	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000668	0.00632	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000663	0.00627	CbGpPWpGaD
Bezafibrate—PPARD—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00066	0.00625	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000649	0.00614	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000623	0.0059	CbGpPWpGaD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000611	0.00578	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000594	0.00562	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000594	0.00562	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000589	0.00557	CbGpPWpGaD
Bezafibrate—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000584	0.011	CbGeAlD
Bezafibrate—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000562	0.0106	CbGeAlD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000552	0.00522	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000543	0.00514	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000519	0.00491	CbGpPWpGaD
Bezafibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000517	0.00489	CbGpPWpGaD
Bezafibrate—PPARD—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000516	0.00489	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000506	0.00479	CbGpPWpGaD
Bezafibrate—CYP1A1—Oxidative Stress—SOD1—amyotrophic lateral sclerosis	0.000506	0.00479	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000505	0.00478	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.000502	0.00475	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000501	0.00474	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000487	0.00461	CbGpPWpGaD
Bezafibrate—CYP2C8—brain—amyotrophic lateral sclerosis	0.000484	0.00911	CbGeAlD
Bezafibrate—PPARA—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000478	0.00453	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000478	0.00453	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000475	0.00449	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000449	0.00425	CbGpPWpGaD
Bezafibrate—CYP1A1—brain—amyotrophic lateral sclerosis	0.000447	0.0084	CbGeAlD
Bezafibrate—PPARD—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000446	0.00422	CbGpPWpGaD
Bezafibrate—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000429	0.00807	CbGeAlD
Bezafibrate—PPARA—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000428	0.00405	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000427	0.00404	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000425	0.00403	CbGpPWpGaD
Bezafibrate—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000413	0.00777	CbGeAlD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000389	0.00368	CbGpPWpGaD
Bezafibrate—CYP1A1—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000383	0.00363	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000381	0.00361	CbGpPWpGaD
Bezafibrate—Balsalazide—PTGS2—amyotrophic lateral sclerosis	0.000376	0.694	CrCbGaD
Bezafibrate—PPARA—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000371	0.00351	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000362	0.00342	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000356	0.00337	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000354	0.00335	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000347	0.00328	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000347	0.00328	CbGpPWpGaD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.000344	0.00326	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000343	0.00324	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00034	0.00322	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00034	0.00322	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000335	0.00317	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000325	0.00308	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000324	0.00306	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000322	0.00304	CbGpPWpGaD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.00032	0.00302	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000317	0.003	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000314	0.00298	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000309	0.00293	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000306	0.0029	CbGpPWpGaD
Bezafibrate—SLCO1B1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000306	0.0029	CbGpPWpGaD
Bezafibrate—CYP1A1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000301	0.00285	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000295	0.00279	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000289	0.00274	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000289	0.00274	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000288	0.00272	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000285	0.0027	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000279	0.00264	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000277	0.00263	CbGpPWpGaD
Bezafibrate—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000276	0.00261	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000276	0.00261	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000273	0.00259	CbGpPWpGaD
Bezafibrate—CYP1A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000273	0.00258	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.00027	0.00255	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00027	0.00255	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000268	0.00254	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000266	0.00252	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000264	0.0025	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000264	0.0025	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000264	0.0025	CbGpPWpGaD
Bezafibrate—SLCO1B1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00026	0.00246	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—DAO—amyotrophic lateral sclerosis	0.000251	0.00237	CbGpPWpGaD
Bezafibrate—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00025	0.00237	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000247	0.00233	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000246	0.00233	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000244	0.00231	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000242	0.00229	CbGpPWpGaD
Bezafibrate—HMGCR—AMPK Signaling—TP53—amyotrophic lateral sclerosis	0.000242	0.00229	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000241	0.00229	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000236	0.00223	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000234	0.00222	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000234	0.00222	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000234	0.00222	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000233	0.00221	CbGpPWpGaD
Bezafibrate—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000232	0.0022	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000231	0.00219	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000225	0.00213	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000225	0.00213	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000219	0.00207	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000212	0.00201	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—amyotrophic lateral sclerosis	0.000212	0.00201	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000211	0.002	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00021	0.00199	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—DAO—amyotrophic lateral sclerosis	0.000209	0.00198	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000209	0.00198	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000201	0.00191	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000193	0.00183	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000193	0.00182	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000192	0.00182	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000191	0.00181	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00019	0.0018	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000189	0.00179	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000189	0.00179	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000184	0.00174	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000182	0.00172	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000179	0.00169	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000179	0.00169	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000177	0.00167	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000176	0.00167	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GSR—amyotrophic lateral sclerosis	0.000175	0.00166	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000173	0.00164	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000171	0.00162	CbGpPWpGaD
Bezafibrate—CYP1A1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00017	0.00161	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000169	0.0016	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000168	0.00159	CbGpPWpGaD
Bezafibrate—Indomethacin—PTGS2—amyotrophic lateral sclerosis	0.000166	0.306	CrCbGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000164	0.00155	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000161	0.00152	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00016	0.00151	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000158	0.0015	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000157	0.00149	CbGpPWpGaD
Bezafibrate—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000156	0.00147	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000156	0.00147	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000154	0.00146	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000152	0.00144	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000151	0.00143	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000149	0.00141	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000149	0.00141	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GSR—amyotrophic lateral sclerosis	0.000146	0.00138	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000145	0.00137	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000144	0.00136	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000143	0.00135	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000139	0.00132	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—DAO—amyotrophic lateral sclerosis	0.000137	0.0013	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000136	0.00129	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000134	0.00127	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000134	0.00127	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000133	0.00126	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000132	0.00125	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000132	0.00125	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000131	0.00124	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000129	0.00122	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000128	0.00121	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000127	0.0012	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000122	0.00116	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000122	0.00115	CbGpPWpGaD
Bezafibrate—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00012	0.00114	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00012	0.00114	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000119	0.00113	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000118	0.00112	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000115	0.00109	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000112	0.00106	CbGpPWpGaD
Bezafibrate—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00011	0.00104	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00011	0.00104	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00011	0.00104	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000108	0.00102	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000105	0.000998	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000104	0.000983	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.0001	0.000948	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSR—amyotrophic lateral sclerosis	9.58e-05	0.000907	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	9.39e-05	0.000889	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	9.35e-05	0.000885	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	9.35e-05	0.000885	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.01e-05	0.000853	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.73e-05	0.000826	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.72e-05	0.000825	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	8.57e-05	0.000812	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	8.57e-05	0.000812	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	8.55e-05	0.00081	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.18e-05	0.000774	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.99e-05	0.000757	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.95e-05	0.000753	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CHAT—amyotrophic lateral sclerosis	7.87e-05	0.000745	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	7.84e-05	0.000742	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.74e-05	0.000733	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	7.54e-05	0.000714	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.5e-05	0.00071	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	7.48e-05	0.000708	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.29e-05	0.00069	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.18e-05	0.00068	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.12e-05	0.000674	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.87e-05	0.00065	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.86e-05	0.00065	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	6.85e-05	0.000649	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	6.76e-05	0.00064	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MMP9—amyotrophic lateral sclerosis	6.74e-05	0.000638	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	6.73e-05	0.000637	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.45e-05	0.000611	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	6.2e-05	0.000587	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.2e-05	0.000586	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	6.05e-05	0.000573	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.01e-05	0.000568	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.93e-05	0.000561	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.92e-05	0.000561	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.9e-05	0.000559	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—APOE—amyotrophic lateral sclerosis	5.86e-05	0.000554	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.65e-05	0.000535	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.42e-05	0.000513	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	5.12e-05	0.000485	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.92e-05	0.000466	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—APOE—amyotrophic lateral sclerosis	4.88e-05	0.000462	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.83e-05	0.000457	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	4.73e-05	0.000448	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	4.7e-05	0.000445	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	4.6e-05	0.000436	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	4.6e-05	0.000436	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—APOE—amyotrophic lateral sclerosis	4.46e-05	0.000422	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.34e-05	0.000411	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	4.34e-05	0.00041	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.31e-05	0.000408	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.23e-05	0.0004	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	4.21e-05	0.000398	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.01e-05	0.00038	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.95e-05	0.000374	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.91e-05	0.00037	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.89e-05	0.000368	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.88e-05	0.000368	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.87e-05	0.000367	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.68e-05	0.000348	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	3.56e-05	0.000337	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.54e-05	0.000335	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.34e-05	0.000316	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.33e-05	0.000315	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	3.33e-05	0.000315	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.25e-05	0.000307	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOE—amyotrophic lateral sclerosis	3.2e-05	0.000303	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.06e-05	0.00029	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.06e-05	0.000289	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.52e-05	0.000239	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	2.52e-05	0.000238	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.43e-05	0.00023	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.33e-05	0.00022	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.23e-05	0.000211	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.19e-05	0.000207	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.09e-05	0.000198	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.92e-05	0.000182	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.91e-05	0.000181	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.91e-05	0.000181	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.76e-05	0.000166	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.73e-05	0.000163	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.58e-05	0.000149	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.45e-05	0.000137	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.08e-05	0.000102	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.03e-05	9.72e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.91e-06	9.38e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.44e-06	8.93e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	7.77e-06	7.35e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.32e-06	5.04e-05	CbGpPWpGaD
